dorsaVi Reports Growth and Innovation in Q4
Company Announcements

dorsaVi Reports Growth and Innovation in Q4

dorsaVi Limited (AU:DVL) has released an update.

dorsaVi Limited reported a 10% increase in Q4 sales revenue to $363k, with an annualized recurring revenue of $1.1m, signaling consistent growth. The company also completed a pivotal data agreement with Norton Healthcare, advancing its presence in the US healthcare market. Additionally, dorsaVi launched innovative AI-based features for their wearable sensor technology, aimed at broadening their reach in different healthcare sectors.

For further insights into AU:DVL stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App